Viatris to receive exclusive global development & commercialization rights to 2 Phase 3 assets as well as the potential to add additional assets in the future.
The temperature of chromatographic operations at manufacturing scale which utilize a chilled mobile phase can be difficult to replicate in a scale down model.
Aims to be a supportive ecosystem for early-stage biotech companies, providing a range of tailored services to help them navigate concept to commercialization.
Aim to help life sciences companies meet regulatory requirements and standards for quality and safety in the drug development and manufacturing life cycle.